Dr. Reddy's' Miryalaguda plant issued with Form 483 after US FDA audit
Dr Reddy’s Laboratories has been issued with a Form 483 after an inspection at its active pharmaceutical ingredient (API) plant in Miryalaguda in Telangana, India.
Archives for February 23, 2017
Biolabex's Mauritius R&D lab open for business
Biolabex has opened a manufacturing and R&D laboratory at BioPark Mauritius, a biohub in Vacoas-Phoenix south of the capital Port Louis.
Envigo thyroid hormone assay meets OECD guidelines
Envigo has developed and validated an analytical method to evaluate the potential effects of thyroid hormone levels in rat F1 offspring.
Ohr Pharmaceutical Inc. shuts sustained release tech lab
Ohr Pharmaceutical Inc. has halted activities at the laboratory in San Diego, California where research on its sustained release delivery technology was carried out.
Gov’t delay could postpone ClinicalTrials.gov usability, patient recruitment
Several organizations have penned an open letter to NIH urging it adhere to 21st Century Cures deadlines that if missed, will affect improvements to ClinicalTrials.gov – and ultimately, study start up.